Dow Up 0.08% Nasdaq Down 0.30%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.46 Down 0.08(3.15%) Sep 19, 4:00PM EDT
|After Hours : 2.46 0.00 (0.00%) Sep 19, 6:02PM EDT
Prev Close:2.54
Open:2.54
Bid:2.30 x 1000
Ask:2.70 x 33600
1y Target Est:7.00
Beta:3.29
Next Earnings Date:N/A
Day's Range:2.44 - 2.58
52wk Range:1.53 - 6.87
Volume:797,754
Avg Vol (3m):1,200,860
Market Cap:206.07M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRADown 3.15%206.07M
DVAXUp 6.67%378.55M
PFEDown 0.59%192.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,091.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback